{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:35:25Z","timestamp":1793061325379,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473858"],"award-info":[{"award-number":["82473858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xcrm.2026.102909","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:43:22Z","timestamp":1782917002000},"page":"102909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted DNA triplex-forming oligonucleotide liposome for pulmonary fibrosis gene therapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Jiarui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chicheng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanliang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102909_bib1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary fibrosis: from pathogenesis to clinical decision-making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102909_bib3","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1172\/JCI60323","article-title":"Pulmonary fibrosis: patterns and perpetrators","volume":"122","author":"Noble","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102909_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bjh.19840","article-title":"Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: a British Society for Haematology Good Practice Paper","volume":"206","author":"Barrett","year":"2025","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2026.102909_bib5","unstructured":"Website: Human prescription drug label: BLEOMYCIN- bleomycin sulfate injection, powder, lyophilized, for solution. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=b5806c40-12ce-48e3-8abd-9f8997ef4428"},{"key":"10.1016\/j.xcrm.2026.102909_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","article-title":"The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis","volume":"96","author":"Munger","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102909_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib8","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib9","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1164\/rccm.202206-1041ST","article-title":"Syndrome of combined pulmonary fibrosis and emphysema: an official ATS\/ERS\/JRS\/ALAT research statement","volume":"206","author":"Cottin","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib10","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2213-2600(18)30339-4","article-title":"Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON","volume":"7","author":"Crestani","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib12","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib13","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102909_bib14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00005","article-title":"The clinical course of patients with idiopathic pulmonary fibrosis","volume":"142","author":"Martinez","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib72","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMra003200","article-title":"Idiopathic pulmonary fibrosis","volume":"345","author":"Gross","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/smll.201202310","article-title":"IsoDGR-tagged albumin: a new \u03b1v\u03b23 selective carrier for nanodrug delivery to tumors","volume":"9","author":"Curnis","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.xcrm.2026.102909_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.bi.64.070195.000433","article-title":"Triplex DNA structures","volume":"64","author":"Frank-Kamenetskii","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.xcrm.2026.102909_bib18","doi-asserted-by":"crossref","first-page":"15210","DOI":"10.1002\/anie.201701868","article-title":"Triplex DNA nanostructures: from basic properties to applications","volume":"56","author":"Hu","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.xcrm.2026.102909_bib19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/nar\/gkx1230","article-title":"Triplex-forming oligonucleotides: a third strand for DNA nanotechnology","volume":"46","author":"Chandrasekaran","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102909_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0033583502003773","article-title":"Triplex-forming oligonucleotides: principles and applications","volume":"35","author":"Vasquez","year":"2002","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.xcrm.2026.102909_bib21","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3390\/pharmaceutics15102515","article-title":"Recent advancements in development and therapeutic applications of genome-targeting triplex-forming oligonucleotides and peptide nucleic acids","volume":"15","author":"Mikame","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xcrm.2026.102909_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/70155","article-title":"Sequence-specific gene targeting using triplex strategies","volume":"17","author":"Helene","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102909_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s001090050112","article-title":"Triplex DNA: fundamentals, advances, and potential applications for gene therapy","volume":"75","author":"Chan","year":"1997","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib24","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1021\/bc1000388","article-title":"Targeted DNA methylation by a DNA methyltransferase coupled to a triple helix forming oligonucleotide to down-regulate the epithelial cell adhesion molecule","volume":"21","author":"van der Gun","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.xcrm.2026.102909_bib25","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1541-7786.MCR-12-0567","article-title":"Towards sustained silencing of HER2\/neu in cancer by epigenetic editing","volume":"11","author":"Falahi","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102909_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41587-021-01057-5","article-title":"Direct targeting of amplified gene loci for proapoptotic anticancer therapy","volume":"40","author":"Kaushik Tiwari","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102909_bib27","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1073\/pnas.97.8.3862","article-title":"Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides","volume":"97","author":"Faria","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102909_bib28","first-page":"3790","article-title":"Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells","volume":"60","author":"McGuffie","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102909_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.xcrm.2026.102909_bib30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1183\/09031936.98.11040912","article-title":"Expression of plasminogen activator inhibitors type-1 and type-2 in the mouse lung after administration of crystalline silica","volume":"11","author":"Lardot","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.xcrm.2026.102909_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ncomms1776","article-title":"CYLD negatively regulates transforming growth factor-\u03b2-signalling via deubiquitinating Akt","volume":"3","author":"Lim","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102909_bib32","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1074\/jbc.M109.025684","article-title":"SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin","volume":"285","author":"Chang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.102909_bib33","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1172\/JCI118201","article-title":"Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse","volume":"96","author":"Olman","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102909_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41573-019-0040-5","article-title":"Targeting metabolic dysregulation for fibrosis therapy","volume":"19","author":"Zhao","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102909_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9440(10)63674-7","article-title":"Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1","volume":"163","author":"Chuang-Tsai","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2026.102909_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/thx.2009.119974","article-title":"Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis","volume":"65","author":"Senoo","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.xcrm.2026.102909_bib37","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI10531","article-title":"Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice","volume":"106","author":"Hattori","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102909_bib38","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1073\/pnas.93.9.4320","article-title":"Prediction of the stability of DNA triplexes","volume":"93","author":"Roberts","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102909_bib39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/nar\/gkh188","article-title":"Triplex-forming oligonucleotide target sequences in the human genome","volume":"32","author":"Go\u00f1i","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102909_bib40","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1021\/acs.molpharmaceut.2c00313","article-title":"68Ga-labeled cystine knot peptide targeting integrin \u03b1v\u03b26 for lung cancer PET imaging","volume":"19","author":"Ren","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.xcrm.2026.102909_bib41","unstructured":"Website: Mouse hematology. https:\/\/www.criver.com\/sites\/default\/files\/resources\/doc_a\/C57BL6MouseClinicalPathologyData.pdf; https:\/\/www.criver.com\/sites\/default\/files\/resources\/doc_a\/BALBcMouseClinicalPathologyData.pdf."},{"key":"10.1016\/j.xcrm.2026.102909_bib42","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0002-9440(10)63196-3","article-title":"The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism","volume":"164","author":"Hattori","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2026.102909_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2011.06.037","article-title":"Targeted TFO delivery to hepatic stellate cells","volume":"155","author":"Yang","year":"2011","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.xcrm.2026.102909_bib44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/nar\/gkg198","article-title":"Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide","volume":"31","author":"Carbone","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102909_bib45","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/82348","article-title":"Triplex technology takes off","volume":"18","author":"Giovannangeli","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102909_bib46","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1093\/nar\/26.21.4996","article-title":"Circular dichroism and UV melting studies on formation of an intramolecular triplex containing parallel T\u2217A:T and G\u2217G:C triplets: netropsin complexation with the triplex","volume":"26","author":"Gondeau","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102909_bib47","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1021\/bi010666l","article-title":"pH and cation effects on the properties of parallel pyrimidine motif DNA triplexes","volume":"40","author":"Sugimoto","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.xcrm.2026.102909_bib48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1432-1033.1997.00424.x","article-title":"A kinetic study of triple-helix formation at a critical R x Y sequence of the murine c-Ki-ras promoter by (A,G)- and (G,T) oligonucleotides","volume":"248","author":"Xodo","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.xcrm.2026.102909_bib49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/07391102.2003.10506922","article-title":"Resolution of parallel and antiparallel oligonucleotide triple helices formation and melting processes by multivariate curve resolution","volume":"21","author":"Jaumot","year":"2003","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.xcrm.2026.102909_bib50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102909_bib51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2141.2012.09074.x","article-title":"PAI-1, progress in understanding the clinical problem and its aetiology","volume":"157","author":"Iwaki","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2026.102909_bib52","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41420-021-00439-7","article-title":"Human pluripotent stem-cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing","volume":"7","author":"Kim","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.xcrm.2026.102909_bib54","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd3266","article-title":"Integrins as therapeutic targets: lessons and opportunities","volume":"9","author":"Cox","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102909_bib55","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1021\/acs.jmedchem.8b01123","article-title":"isoDGR-peptides for integrin targeting: is the time up for RGD?","volume":"61","author":"H\u00f6ltke","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.xcrm.2026.102909_bib56","doi-asserted-by":"crossref","first-page":"7702","DOI":"10.1002\/anie.201202032","article-title":"Molecular dynamics reveal that isoDGR-containing cyclopeptides are true \u03b1v\u03b23 antagonists unable to promote integrin allostery and activation","volume":"51","author":"Ghitti","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.xcrm.2026.102909_bib57","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s10495-023-01921-6","article-title":"Exploring the role of ITGB6: fibrosis, cancer, and other diseases","volume":"29","author":"Zhang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.xcrm.2026.102909_bib58","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1038\/s41467-020-18397-6","article-title":"Translational pharmacology of an inhaled small molecule \u03b1v\u03b26 integrin inhibitor for idiopathic pulmonary fibrosis","volume":"11","author":"John","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102909_bib59","doi-asserted-by":"crossref","first-page":"13094","DOI":"10.1021\/acsnano.1c02337","article-title":"Protamine-Controlled Reversible DNA Packaging: A Molecular Glue","volume":"15","author":"Mukherjee","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2026.102909_bib60","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1183\/16000617.00008414","article-title":"Coagulation and anticoagulation in idiopathic pulmonary fibrosis","volume":"24","author":"Crooks","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.xcrm.2026.102909_bib61","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/aps.2010.90","article-title":"Hepatocyte growth factor in lung repair and pulmonary fibrosis","volume":"32","author":"Panganiban","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.xcrm.2026.102909_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq0703","article-title":"Enzyme-like nanoparticle-engineered mesenchymal stem cell secreting HGF promotes visualized therapy for idiopathic pulmonary fibrosis in vivo","volume":"10","author":"Bao","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102909_bib63","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102909_bib64","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.2147\/IJN.S207837","article-title":"Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene","volume":"14","author":"Yan","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.xcrm.2026.102909_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2026.102909_bib66","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41586-024-07660-1","article-title":"Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis","volume":"631","author":"Tsukui","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102909_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00128336","article-title":"MOPAC: a semiempirical molecular orbital program","volume":"4","author":"Stewart","year":"1990","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.xcrm.2026.102909_bib68","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/nsmb.2905","article-title":"Structural determinants of integrin \u03b2-subunit specificity for latent TGF-\u03b2","volume":"21","author":"Dong","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.102909_bib69","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.xcrm.2026.102909_bib70","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.xcrm.2026.102909_bib71","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1016\/j.bmcl.2018.09.001","article-title":"Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis","volume":"28","author":"Islam","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:27:03Z","timestamp":1793060823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126003265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666379126003265"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102909","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted DNA triplex-forming oligonucleotide liposome for pulmonary fibrosis gene therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102909"}}